CPRX - Catalyst Pharmaceuticals Inc. (CPRX) CEO Patrick McEnany on Q2 2021 Results - Earnings Call Transcript
Catalyst Pharmaceuticals, Inc. (CPRX) Q2 2021 Earnings Conference Call August 10, 2021 08:30 ET Company Participants Ali Grande - Chief Financial Officer Patrick McEnany - Chairman and Chief Executive Officer Steven Miller - Chief Operating Officer and Chief Scientific Officer Jeffrey Del Carmen - Chief Commercial Officer Gary Ingenito - Chief Medical and Regulatory Officer Conference Call Participants Charles Duncan - Cantor Fitzgerald Presentation Operator Greetings and welcome to the Catalyst Pharmaceuticals Incorporated Second Quarter 2021 Results. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Ms. Ali Grande, Chief Financial Officer. Thank you. You may begin. Ali Grande Good morning, everyone and thank you for joining our conference call to discuss Catalyst’s second quarter 2021 financial results and corporate highlights. Leading
For further details see:
Catalyst Pharmaceuticals, Inc. (CPRX) CEO Patrick McEnany on Q2 2021 Results - Earnings Call Transcript